Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii507
Main Authors Wislez, M., Blons, H., Domblides, C., Barlesi, F., Mazieres, J., Monnet, I., Kiakouama Maleka, L., Quantin, X., Taillade, L., Lena, H., Fraisse, P., Janicot, H., Audigier Valette, C., Amour, E., Langlais, A., Rabbe, N., Cadranel, J., Laurent puig, P., Lavolé, A.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text
ISSN0923-7534
1569-8041
DOI10.1093/annonc/mdy292.027

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy292.027